Home › Funds › Patient Capital Management, LLC › PGEN
Patient Capital Management, LLC position in PGEN
PRECIGEN INC · Health Care
Patient Capital Management, LLC reported holding 17,950,104 shares of PGEN (PRECIGEN INC) in its Q3 2026 13F filing — a position valued at US$153.7M, representing 5.19% of its reported portfolio and ranking #7 among its reported holdings. Patient Capital Management, LLC has disclosed PGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Capital Management, LLC's PGEN position evolved
Patient Capital Management, LLC first disclosed a stake in PGEN in Q3 2023 at 13,753,176 shares (US$19.5M). The position peaked in Q3 2026 at 17,950,104 shares, worth US$153.7M. Across 13 filings, Patient Capital Management, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 17,950,104 shares valued at US$153.7M — a reduction of -1,086,872 shares quarter over quarter.. Notable position changes include a 63% increase in Q3 2025 (shares rose 27% over the following quarter), a 29% trim in Q4 2025 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 13.75M | $19.53M | New |
| Q4 2023 | 15.98M | $21.42M | Add |
| Q1 2024 | 17.45M | $25.31M | Add |
| Q2 2024 | 18.17M | $28.72M | Add |
| Q3 2024 | 17.94M | $16.99M | Reduce |
| Q4 2024 | 17.88M | $20.03M | Hold |
| Q1 2025 | 17.37M | $25.88M | Reduce |
| Q2 2025 | 16.27M | $23.10M | Reduce |
| Q3 2025 | 26.46M | $87.06M | Add |
| Q4 2025 | 18.67M | $78.06M | Reduce |
| Q1 2026 | 17.82M | $68.95M | Reduce |
| Q2 2026 | 19.04M | $108.51M | Add |
| Q3 2026 | 17.95M | $153.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PGEN and 13F data
PGEN (PRECIGEN INC) is a Health Care company. 66 other funds we track also report a position in PGEN — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$36.6M), Boxer Capital Management, LLC (US$29.4M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$26.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PGEN
- TANG CAPITAL MANAGEMENT LLC 6.42M sh · $36.58M · Q2 2026
- Boxer Capital Management, LLC 5.15M sh · $29.36M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 3.06M sh · $26.23M · Q3 2026
- Diametric Capital, LP 1.41M sh · $8.05M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 683.42K sh · $5.85M · Q3 2026
- LexAurum Advisors, LLC 633.53K sh · $5.42M · Q3 2026
- Lansing Street Advisors 498.52K sh · $4.27M · Q3 2026
- GMT CAPITAL CORP 668.83K sh · $3.81M · Q2 2026
- Virtus Investment Advisers, LLC 378.76K sh · $3.24M · Q3 2026
- Occam Crest Management LP 35.50K sh · $2.49M · Q2 2026
More on Patient Capital Management, LLC
FAQ
How long has Patient Capital Management, LLC held PGEN?
Patient Capital Management, LLC has disclosed PGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Patient Capital Management, LLC's current position in PGEN?
As of Q3 2026, Patient Capital Management, LLC holds 17.95M shares of PGEN (PRECIGEN INC), valued at $153.65M, representing 5.19% of its reported portfolio and ranking #7.
Has Patient Capital Management, LLC been buying or selling PGEN?
In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in PGEN. The position peaked in Q3 2026 at 17.95M shares.
Which other funds hold PGEN?
Other major institutional holders of PGEN include TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.